Balantidium coli infections exhibit a global distribution, with higher prevalence observed in regions where poor sanitation and inadequate water treatment are prevalent. The parasite is more commonly reported in areas with close human-pig interactions, emphasizing the zoonotic nature of the infection. Occupations involving direct contact with pigs, such as farmers and veterinarians, are considered at higher risk. Additionally, immunocompromised individuals, including those with HIV/AIDS, may experience more severe and prolonged balantidiasis. Understanding the epidemiology of Balantidium infections is crucial for implementing targeted control measures. Efforts to improve sanitation infrastructure, raise public awareness about proper hygiene practices, and provide access to clean water contribute to reducing the incidence of balantidiasis. Surveillance and monitoring programs help track the prevalence of the parasite, identify emerging hotspots, and guide public health interventions to mitigate the impact of Balantidium coli infections on human health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain